OPNT - Opiant Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 550.24M
Enterprise Value 329.22M
Trailing P/E 60.91
Forward P/E 1-41.38
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)1.34
Price/Book (mrq)1.55
Enterprise Value/Revenue 30.78
Enterprise Value/EBITDA 649.77

Trading Information

Stock Price History

Beta (5Y Monthly) 0.22
52-Week Change 3-15.55%
S&P500 52-Week Change 315.52%
52 Week High 318.23
52 Week Low 39.98
50-Day Moving Average 312.84
200-Day Moving Average 314.20

Share Statistics

Avg Vol (3 month) 314.86k
Avg Vol (10 day) 320.02k
Shares Outstanding 54.19M
Float 3M
% Held by Insiders 116.23%
% Held by Institutions 129.53%
Shares Short (Jan 30, 2020) 47.32k
Short Ratio (Jan 30, 2020) 40.51
Short % of Float (Jan 30, 2020) 40.20%
Short % of Shares Outstanding (Jan 30, 2020) 40.17%
Shares Short (prior month Dec 30, 2019) 415.84k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:100
Last Split Date 3Dec 30, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin 2.63%
Operating Margin (ttm)1.48%

Management Effectiveness

Return on Assets (ttm)0.99%
Return on Equity (ttm)3.48%

Income Statement

Revenue (ttm)37.61M
Revenue Per Share (ttm)9.52
Quarterly Revenue Growth (yoy)372.80%
Gross Profit (ttm)-9.71M
EBITDA 587.12k
Net Income Avi to Common (ttm)988.68k
Diluted EPS (ttm)0.20
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)23.22M
Total Cash Per Share (mrq)5.67
Total Debt (mrq)851k
Total Debt/Equity (mrq)2.69
Current Ratio (mrq)4.28
Book Value Per Share (mrq)7.76

Cash Flow Statement

Operating Cash Flow (ttm)-3.01M
Levered Free Cash Flow (ttm)-3.6M